Mount Sinai School of Medicine, Department of Psychiatry, New York, NY 10029, USA.
Neurobiol Aging. 2012 Jun;33(6):1125.e1-8. doi: 10.1016/j.neurobiolaging.2011.08.017. Epub 2011 Dec 27.
Recent evidence shows that despite high incidence of dementia in the very old, they exhibit significantly lower levels of Alzheimer's disease (AD) neuropathology relative to younger persons with dementia. The levels and distributions of some synaptic proteins have been found to be associated with dementia severity, even in the oldest-old, but the molecular and functional nature of these deficits have not been studied in detail. The objective of this study was to assess the relationship of dementia with gene and protein expression of a panel of synaptic markers associated with different synaptic functions in young-, middle-, and oldest-old individuals. The protein and messenger RNA (mRNA) levels of 7 synaptic markers (complexin-1, complexin-2, synaptophysin, synaptobrevin, syntaxin, synaptosomal-associated protein 25 (SNAP-25), and septin-5) were compared in the brains of nondemented and demented individuals ranging from 70 to 103 years of age. One hundred eleven brains were selected to have either no significant neuropathology or only AD-associated pathology (neuritic plaques [NPs] and neurofibrillary tangles [NFTs]). The cohort was then stratified into tertiles as young-old (70-81 years old), middle-old (82-88), and oldest-old (89-103). The brains of persons with dementia evidenced significantly lower levels of gene and protein expression of synaptic markers regardless of age. Importantly, dementia was associated with reductions in all measured synaptic markers irrespective of their role(s) in synaptic function. Although other dementia-associated hallmarks of AD neuropathology (neuritic plaques and neurofibrillary tangles) become less prominent with increasing age, synaptic marker abnormalities in dementia remain constant with increasing age and may represent an independent substrate of dementia spanning all ages.
最近的证据表明,尽管非常老的人群中痴呆症的发病率很高,但与痴呆症的年轻患者相比,他们的阿尔茨海默病(AD)神经病理学水平显著较低。已经发现一些突触蛋白的水平和分布与痴呆症的严重程度有关,即使在最年长的人群中也是如此,但这些缺陷的分子和功能性质尚未得到详细研究。本研究的目的是评估痴呆症与一组与不同突触功能相关的突触标志物的基因和蛋白表达之间的关系,这些标志物与年轻、中年和最年长个体有关。在年龄在 70 至 103 岁之间的非痴呆和痴呆个体的大脑中比较了 7 种突触标志物(复合蛋白-1、复合蛋白-2、突触小体蛋白、突触小泡相关蛋白 25(SNAP-25)和 5 号胞裂蛋白)的蛋白和信使 RNA(mRNA)水平。选择了 111 个大脑,这些大脑要么没有明显的神经病理学变化,要么只有 AD 相关的病理学(神经纤维缠结[NFTs]和神经原纤维缠结[NPs])。然后,将队列分为三个三分位数,即年轻老年人(70-81 岁)、中年老年人(82-88 岁)和最年长老年人(89-103 岁)。无论年龄大小,痴呆症患者的大脑中突触标志物的基因和蛋白表达水平均明显降低。重要的是,无论突触功能如何,痴呆症都与所有测量的突触标志物的减少有关。尽管 AD 神经病理学的其他痴呆相关标志物(神经纤维缠结和神经原纤维缠结)随着年龄的增长变得不那么明显,但随着年龄的增长,痴呆症中的突触标志物异常仍然保持不变,并且可能代表跨越所有年龄段的痴呆症的独立基质。